Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
The PHI UNIVERSITY CLINIC FOR RADIOTHERAPY AND ONCOLOGY has issued a Tender notice for the procurement of a Procurement of Drugs for 2026 Biological Therapy in the Macedonia. This Tender notice was published on 25 Apr 2026 and is scheduled to close on 14 May 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 140137958, while the tender notice number is 07175/2026 and Registering on the platform.
Procurement Summary
Country: Macedonia
Summary: Procurement of Drugs for 2026 Biological Therapy
Deadline: 14 May 2026
Posting Date: 25 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140137958
Document Ref. No.: 07175/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
33600000 - Pharmaceutical productsPurchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details Tender Details A detailed description can be found in the tender documentation1 L01ED03 Alectinib 150 mg, 2 L01FF05 Atezolizumab 1875 mg/15 ml, 3 L01EK01 Axitinib, 4 L01FG01 Bevacizumab originator, 5 L01FG01 Bevacizumab biosimilar, 6 L01EE02 Cobimetinib, 7 Cetuximab solution for infusion 5 mg/mlx20 ml, 8 L01XE03 Erlotinib, 9 L02BA03 Fulvestrant 250 mg, 10 L01XA03 Oxaliplatin 50 mg, 11 L01XA03 Oxaliplatin 100 mg, 12 L01FF02 Pembrolizumab, 13 L01EX03 Pazopanib, 14 L01XE33 Palbociclib 125 mg, 15 L01XE33 Palbociclib 100 mg, 16 L01XE33 Palbociclib 75 mg, 17 L01BA04 Pemetrexed 25mg/ml, 18 L01EF02 Ribociclib 200 mg, 19 L01EX01 Sunitinib 50mg, 20 L01XE05/L01EX02 Sorafenib 200 mg, 21 L01FD03 Trastuzumab emtansine 100 mg/15 ml, 22 L01XC014 Trastuzumab emtansine 160 mg/20 ml, 23 L01XY02 Pertuzumab/ trastuzumab 1200 mg/600 mg, 24 L01XY02 Pertuzumab/trastuzumab 600mg/600 mg, 25 L02BX03 Abiraterone 250 mg, 26 L02BX03 Abiraterone 500 mg, 27 L01XE15 Vemurafenib 240 mg, 28 L01XE35 Osimertinib 80 mg, 29 L01ED05 Lorlatinib 100 mg, 30 L01FF01 Nivolumab 40 mg, 31 L01FF01 Nivolumab 100 mg, 32 M05BX04 Denosumab 120 MG, 33 L01XC11 Ipilimumab 5mg/mlx10ml, 34 L01FF03 Durvalumab 50 mg/mlx10ml, 35 L01XE23 Dabrafenib 75 mg, 36 L01EE01 Trametinib 2 mg, 37 L02BB06 Darolutamide 300 mg, 38 L01FF04 Avelumab 20 mg/mlx10ml, 39 L01XK01 Olaparib 150mg (56 tab), 40 L01EM06 Inavolisib 9 mg, 41 L01EX27 Capivasertib 200mg, Documents
CPV Descriptions: Pharmaceutical products
Similar Tenders
Macedonia
151782680
16 Nov 2026
Refer Document
Procurement Documents for Macedonia
Access a comprehensive library of standard procurement documents specific to Macedonia. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in Macedonia
Want To Bid in This Tender?
Get Local Agent Support in Macedonia and 60 More Countries.
View Tenders By
Sign in with Google